Norman Lamb (North Norfolk, Liberal Democrat)
Information on spend by strategic health authorities (SHAs) under the interim cancer drugs funding arrangements in 2010-11 (from October 2010 to the end of March 2011) and under the Cancer Drugs Fund (from April 2011 to the end of December 2012) is shown in the table.
The Radiotherapy Innovation Fund will utilise any underspend in the Cancer Drugs Fund in 2012-13.
|October 2010 to end March 2011||(1)38,254||50,000|
|April 2011 to end March 2012||(1)108,327||200,000|
|April 2012 to end December 2012||117,357||200,000|
|(1) Includes end of year spending commitments. (2) £200 million was available for the Cancer Drugs Fund in 2011-12 and 2012-13. This comprised £140 million allocated to the NHS and a further £60 million made available for SHAs to draw down as needed. Source: Information supplied to the Department by strategic health authorities|